Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Equillium
Equillium
Equillium’s lupus drug improves kidney biomarker, teeing up opt-in decision from Ono
Fierce Biotech
Mon, 04/1/24 - 11:41 am
Equillium
clinical trials
Ono Pharmaceuticals
Life Sciences Companies Ringing the Nasdaq Bell this Week
BioSpace
Thu, 02/4/21 - 08:10 pm
IPOs
NASDAQ
Sana Biotechnology
Sensei Biotherapeutics
Landos Biopharma
Aspira Women's Health
Equillium
Equillium Continues Graft-Versus-Host Disease Trial, Pauses 2 Others
Xconomy
Fri, 03/27/20 - 08:22 pm
Equillium
clinical trials
COVID-19
graft vs host disease
After a Speedy IPO, Equillium Expands Antibody R&D to Renal Disease
Xconomy
Thu, 02/28/19 - 09:17 pm
Equillium
IPOs
R&D
renal disease
Equillium's EQ001 Granted FDA Fast Track Designation for Acute Graft-Versus-Host Disease
CP Wire
Wed, 12/19/18 - 10:36 am
Equillium
graft vs host disease
EQ001
Equillium's EQ001 Granted FDA Fast Track Designation for Acute Graft-Versus-Host Disease
Wed, 12/19/18 - 10:15 am
Equillium
graft vs host disease
Equillium Plans IPO to Fund Clinical Trials for Transplant Drug
Xconomy
Fri, 09/21/18 - 11:02 pm
Equillium
IPOs
organ transplants